1. Home
  2. GBIO vs FTHM Comparison

GBIO vs FTHM Comparison

Compare GBIO & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FTHM
  • Stock Information
  • Founded
  • GBIO 2016
  • FTHM 2010
  • Country
  • GBIO United States
  • FTHM United States
  • Employees
  • GBIO N/A
  • FTHM N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FTHM Real Estate
  • Sector
  • GBIO Health Care
  • FTHM Finance
  • Exchange
  • GBIO Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • GBIO 29.2M
  • FTHM 33.6M
  • IPO Year
  • GBIO 2020
  • FTHM 2020
  • Fundamental
  • Price
  • GBIO $0.38
  • FTHM $1.06
  • Analyst Decision
  • GBIO Strong Buy
  • FTHM Buy
  • Analyst Count
  • GBIO 4
  • FTHM 1
  • Target Price
  • GBIO $7.33
  • FTHM $2.50
  • AVG Volume (30 Days)
  • GBIO 558.2K
  • FTHM 61.8K
  • Earning Date
  • GBIO 08-06-2025
  • FTHM 08-11-2025
  • Dividend Yield
  • GBIO N/A
  • FTHM N/A
  • EPS Growth
  • GBIO N/A
  • FTHM N/A
  • EPS
  • GBIO N/A
  • FTHM N/A
  • Revenue
  • GBIO $24,556,000.00
  • FTHM $357,816,000.00
  • Revenue This Year
  • GBIO N/A
  • FTHM $32.40
  • Revenue Next Year
  • GBIO N/A
  • FTHM $18.04
  • P/E Ratio
  • GBIO N/A
  • FTHM N/A
  • Revenue Growth
  • GBIO 146.47
  • FTHM 5.80
  • 52 Week Low
  • GBIO $0.32
  • FTHM $0.65
  • 52 Week High
  • GBIO $3.65
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 48.07
  • FTHM 46.00
  • Support Level
  • GBIO $0.35
  • FTHM $1.03
  • Resistance Level
  • GBIO $0.41
  • FTHM $1.36
  • Average True Range (ATR)
  • GBIO 0.03
  • FTHM 0.10
  • MACD
  • GBIO -0.00
  • FTHM -0.03
  • Stochastic Oscillator
  • GBIO 30.11
  • FTHM 13.04

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

Share on Social Networks: